EXG™ 12-Lead Wearable ECG — Continuous Diagnostic Monitoring, 3-Day Wear, Radiolucent

The flagship EXG™ configuration — 12-Lead diagnostic ECG in a wearable form factor The EXG™ 12-Lead Wearable ECG is the flagship configuration of the EXG™ platform from C-Booth Innovations. It delivers continuous 12-Lead diagnostic monitoring in a wearable that goes on in under 60 seconds and stays on for up to three days — tolerating diaphoresis and showering across the episode of care. Now available through Heart Medical for U.S. hospitals, EMS agencies, and cath labs. Why the flagship configuration matters Standard 12-Lead ECG carries a documented electrode misapplication rate of 94.2% (Rouan et al., Am J Cardiol 1989; 64(18):1087–1092), and just 2 cm of misplacement can obscure critical ST-segment changes and hide a heart attack (Bond et al. 2012). The EXG™ 12-Lead addresses these failures at the source: the wearable form factor places electrodes at consistent anatomical positions across ED, ICU, medical/surgical, and cardiology, regardless of who deploys it or where. Key features — 12-Lead configuration Continuous diagnostic 12-Lead monitoring across the entire episode of care Expandable to 18-Lead for Right-sided and Posterior visualization — pair with the EXG™ 3-Lead reversible 3-day continuous wear — once skin is prepped, can be worn through diaphoresis and showering for extended monitoring CPR compatible — tolerates Manual & Mechanical CPR (LUCAS); wearable stays on during resuscitation Radiolucent design — supports continuous 12-Lead monitoring throughout imaging procedures without repositioning Single-cable design — single connection enables setup in under 60 seconds; one adapter works across every EXG™ configuration AHA-compliant electrode placement Disposable, per-patient — single-use consumable Universal compatibility — one cable fits any standard ECG monitor Clinical applications EMS / prehospital STEMI transport — 12-Lead ECG in under 60 seconds, motion artifact reduction, universal compatibility with LP15, X Series, and other portable ECG monitors Emergency department triage and continuous diagnostic monitoring ICU and critical care — continuous 12-Lead across multi-day admissions Cardiology consults and pre-stress-echo assessment Cath lab procedures — continuous 12-Lead through diagnostic cath, PCI, TAVR planning, MitraClip delivery (radiolucent, CPR compatible) Peri-procedural monitoring in recovery bays Certifications and compliance Certified for professional medical use: FDA-Registered, AHA-Compliant & ISO-13485 Certified. About C-Booth Innovations EXG™ is manufactured by C-Booth Innovations, a Carlsbad, California medical-technology company founded in 2017 by two emergency room physicians. Explore other configurations The 12-Lead is one of four EXG™ configurations. See the full platform overview at the EXG™ Wearable ECG Platform collection page, or explore the other configurations directly: EXG™ 5-Lead — continuous rhythm monitoring EXG™ 4-Lead (4-Electrode) — EMS rate & rhythm monitoring EXG™ 3-Lead (Reversible) — Right-sided + Posterior visualization Purchase and configuration workflow Request a scoped quote. Share the audience (EMS, hospital, or cath lab), volume estimate, and existing ECG monitor infrastructure. Configuration walkthrough. Confirm 12-Lead is the right primary configuration and whether you also need 3-Lead reversible or 5-Lead alongside. Deployment planning. Coordinate with your biomed / clinical engineering team on integration and applications training. Standing-order supply. EXG™ 12-Lead is disposable per-patient — predictable-volume programs benefit from standing-order setup. Request a Quote → or call +1 (833) 409-4600. Our team responds within one business day.